UNSPSC 51161729: Doxapram hydrochloride hydrate

This classification denotes a cns stimulant with the molecular formula C24H30N2O2.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P5RU6UOQ5Y, chemically known as 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate, (+/-)-, but more generally known as doxapram hydrochloride hydrate, which bears US NIH Compound Identifier 64648.

European Medicines Agency schedules doxapram hydrochloride hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06382MIG. Most nations, for tariff purposes, schedule doxapram hydrochloride hydrate under HS 29349990. SMILES: CCN1CC(C(C1=O)(C2CCCCC2)C3CCCCC3)CCN4CCOCC4.O.CL.

UNSPSC 51161729 Doxapram hydrochloride hydrate is a Commodity code that in practice captures state and local procurement of pharmaceutical products and pharmacy services far broader than the code's nominal scope. Recent solicitations under this code show state and local governments buying naloxone and drug deactivation systems, on-site pharmacy services, generic multi-source pharmaceuticals and OTC products through cooperative purchasing vehicles, and exploring direct-to-manufacturer prescription programs. Issuing bodies span county health departments (Seminole County, Florida), county government employer health plans (Hall County, Georgia), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local participants including Oregon). The code reflects a mix of tactical product procurement and strategic pharmacy benefit management contracting, with public health initiatives, employee group health plans, and Medicaid-equivalent programs all tagged to the same commodity classification.

Geographic activity centers on Florida, Georgia, Texas, and Minnesota, with the multistate cooperative extending to Oregon. Representative recent opportunities include Seminole County, Florida's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023; Hall County, Georgia's RFQ/P #47-010 for on-site pharmacy services at the Family Health Center Clinic in Gainesville with sealed proposals due June 4, 2026, using an 80/20 technical-to-cost scoring structure; Texas Health and Human Services Commission's RFI HHS0017013 exploring direct-to-manufacturer prescription programs, posted April 3, 2026; and Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, requiring distribution through AmerisourceBergen, Cardinal Health, and Morris & Dickson. The code shows active procurement across product supply, services contracting, and cooperative purchasing infrastructure, with no apparent set-aside designations in the recent solicitations.